Patrick Wood
Stock Analyst at Morgan Stanley
(2.96)
# 1,494
Out of 4,944 analysts
103
Total ratings
43.59%
Success rate
1.16%
Average return
Main Sectors:
Stocks Rated by Patrick Wood
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BDX Becton, Dickinson and Company | Maintains: Overweight | $196 → $197 | $195.23 | +0.91% | 5 | Aug 11, 2025 | |
| STE STERIS | Maintains: Overweight | $276 → $295 | $245.52 | +20.15% | 7 | Aug 8, 2025 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $115 → $123 | $128.31 | -4.14% | 2 | Aug 1, 2025 | |
| BLCO Bausch + Lomb | Maintains: Equal-Weight | $12 → $13 | $14.18 | -8.32% | 8 | Aug 1, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Equal-Weight | $78 → $74 | $74.62 | -0.83% | 7 | Jul 31, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Overweight | $71 → $68 | $40.25 | +68.94% | 3 | Jul 15, 2025 | |
| EW Edwards Lifesciences | Maintains: Equal-Weight | $75 → $81 | $76.96 | +5.25% | 9 | Jul 15, 2025 | |
| DXCM DexCom | Maintains: Equal-Weight | $82 → $89 | $80.99 | +9.89% | 8 | Jul 15, 2025 | |
| BAX Baxter International | Maintains: Underweight | $28 → $27 | $24.11 | +11.99% | 5 | Jul 15, 2025 | |
| ALC Alcon | Maintains: Equal-Weight | $90 → $84 | $86.61 | -3.01% | 4 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $20 → $9 | $8.25 | +9.09% | 2 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $80 → $103 | $73.39 | +40.35% | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $120 → $125 | $102.37 | +22.11% | 6 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $110 → $72 | $92.42 | -22.09% | 4 | May 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $191 → $173 | $122.08 | +41.71% | 5 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $45 → $22 | $11.71 | +87.87% | 4 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $104 → $102 | $74.42 | +37.06% | 5 | Dec 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $234 → $317 | $310.10 | +2.23% | 5 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $10 | $9.69 | +3.20% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $50 → $37 | $28.34 | +30.56% | 2 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $135.38 | - | 5 | Dec 11, 2017 |
Becton, Dickinson and Company
Aug 11, 2025
Maintains: Overweight
Price Target: $196 → $197
Current: $195.23
Upside: +0.91%
STERIS
Aug 8, 2025
Maintains: Overweight
Price Target: $276 → $295
Current: $245.52
Upside: +20.15%
TransMedics Group
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $115 → $123
Current: $128.31
Upside: -4.14%
Bausch + Lomb
Aug 1, 2025
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $14.18
Upside: -8.32%
GE HealthCare Technologies
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $78 → $74
Current: $74.62
Upside: -0.83%
PROCEPT BioRobotics
Jul 15, 2025
Maintains: Overweight
Price Target: $71 → $68
Current: $40.25
Upside: +68.94%
Edwards Lifesciences
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $75 → $81
Current: $76.96
Upside: +5.25%
DexCom
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $82 → $89
Current: $80.99
Upside: +9.89%
Baxter International
Jul 15, 2025
Maintains: Underweight
Price Target: $28 → $27
Current: $24.11
Upside: +11.99%
Alcon
Jul 15, 2025
Maintains: Equal-Weight
Price Target: $90 → $84
Current: $86.61
Upside: -3.01%
Jul 15, 2025
Downgrades: Equal-Weight
Price Target: $20 → $9
Current: $8.25
Upside: +9.09%
Jul 15, 2025
Upgrades: Overweight
Price Target: $80 → $103
Current: $73.39
Upside: +40.35%
May 16, 2025
Maintains: Overweight
Price Target: $120 → $125
Current: $102.37
Upside: +22.11%
May 6, 2025
Maintains: Underweight
Price Target: $110 → $72
Current: $92.42
Upside: -22.09%
May 5, 2025
Maintains: Overweight
Price Target: $191 → $173
Current: $122.08
Upside: +41.71%
Mar 5, 2025
Downgrades: Equal-Weight
Price Target: $45 → $22
Current: $11.71
Upside: +87.87%
Dec 6, 2024
Maintains: Equal-Weight
Price Target: $104 → $102
Current: $74.42
Upside: +37.06%
Nov 11, 2024
Maintains: Overweight
Price Target: $234 → $317
Current: $310.10
Upside: +2.23%
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $18 → $10
Current: $9.69
Upside: +3.20%
Jul 15, 2024
Downgrades: Underweight
Price Target: $50 → $37
Current: $28.34
Upside: +30.56%
Dec 11, 2017
Upgrades: Buy
Price Target: n/a
Current: $135.38
Upside: -